A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(10 sites) United States
GSK Investigational Site, Philadelphia, Pennsylvania Argentina
GSK Investigational Site, Ciudad Autonoma Buenos Aires GSK Investigational Site, Ciudad Autonoma de Buenos Aire China
GSK Investigational Site, Beijing GSK Investigational Site, Zhuzhou Greece
GSK Investigational Site, Larissa Japan
GSK Investigational Site, Hokkaido GSK Investigational Site, Tokyo South Korea
GSK Investigational Site, Yongsan-Ku Seoul United Kingdom
GSK Investigational Site, London
Key details Enrollment target
~514 participants
Primary completion
December 2029
Last updated December 2025